Advertisement

Specific Inhibition by BN 52021 and Structurally Related Compounds of the PAF-Acether-lnduced Increase in Cytosolic Free Calcium

  • A. Etienne
  • N. Baroggi
  • P. Braquet
Part of the GWUMC Department of Biochemistry Annual Spring Symposia book series (GWUN)

Abstract

When washed rabbit platelets loaded with the fluorescent probe Quin 2 were stimulated with 2 × 10-9 M PAF-acether, the intracytoplasmic free calcium [Ca2-]i increases to a concentration of about 10–12 times the basal level as shown by the fluorescence change of the preparation. This [Ca2+]i increase seems to initiate, at least partially, platelet aggregation and secretion. Indeed, pretreatment of loaded platelets with the platelet-activating factor receptor antagonist BN 52021 inhibited the PAF-acether-induced [Ca2+]i signal; the inhibition was dose related, and the signal was totally abolished with 3 × 10-6 M of BN 52021. The activity of BN 52021, as observed on platelet aggregation, is specific for PAF-acether stimulation, since it did not antagonize thrombin or A 23187 calcium-induced mobilization. The structurally related compounds BN 52020 and BN 52022 had the same profile of activity but were less potent than 52021; this is correlated with the results obtained on PAF-acether-induced aggregation—IC50(2.5 × 10-10M PAF-acether) 1.4 × 10-7M, 9.0 × l0-7 M, and l.6 × 10-6 M for BN 52021, BN 52020, and BN 52022, respectively. Our results show that BN 52021 is a useful tool to study the stimulus-activity coupling processes underlying PAF-acether action. As it has been postulated that focal release of PAF-acether may exacerbate the development of atherosclerosis, BN 52021 or related compounds could be of interest in this pathology.

Keywords

Human Platelet Free Calcium Cytosolic Free Calcium Rabbit Platelet Cytoplasmic Free Calcium 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Affolter, H., Erne, P., Burgisser. E., and Pletscher, A., 1984, Ca2+ as messenger of 5HT2-receptor stimulation in human blood platelets, Naunyn Schmiedebergs Arch. Pharmacol. 325:337–342.PubMedCrossRefGoogle Scholar
  2. Braquet, P., 1987, The Ginkgolides: Potent platelet-activating factor antagonists isolated from Ginkgo biloba 1. chemistry, pharmacology and clinical applications, Drugs of the Future 12(7):(in press).Google Scholar
  3. Braquet, P., and Godfroid. J. J., 1986, PAF-acether specific binding sites. 2. Design of specific antagonists, TIPS 7:397–403.Google Scholar
  4. Hallam, T. J., Sanchez. A., and Rink, T. J., 1984. Stimulus-response coupling in human platelets. Changes evoked by platelet-activating factor in cytoplasmic free calcium monitored with the fluorescent calcium indicator quin2, Biochem. J. 218(3):819–827.PubMedGoogle Scholar
  5. Sage, S. O., and Rink. T. J., 1985. Inhibition by forskolin of cytosolic calcium rise, shape and change and aggregation in quin2-loaded human platelets. FEBS Lett. 188(1): 135–140.PubMedCrossRefGoogle Scholar
  6. Stimler, N. P., and O’Flaherty, J. T., 1983, Spasmogenic properties of platelet-activating factor: evidence for a direct mechanism in the contractile response of pulmonary tissues, Am. J. Pathol. 113(l):75–84.PubMedGoogle Scholar
  7. Tsien, R. Y., Pozzan, T., and Rink, T. J., 1982, Calcium homeostasis in intact lymphocytes: cytoplasmic free calcium monitored with a new, intracellularly trapped fluorescent indicator, J. Cell Biol. 94(2):325–334.PubMedCrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1987

Authors and Affiliations

  • A. Etienne
    • 1
  • N. Baroggi
    • 1
  • P. Braquet
    • 1
  1. 1.I.H.B. Research LabsLe Plessis RobinsonFrance

Personalised recommendations